ClinicalTrials.Veeva

Menu

Postoperative Sensitivity Following Placement with Different Restorative Materials in Vital Posterior Teeth (GCP)

L

Liaquat University of Medical & Health Sciences

Status and phase

Completed
Phase 4

Conditions

Sensitivity, Tooth

Treatments

Drug: Tetric N Bond Universal®
Drug: Self Etch Tetric N Bond Universal®
Drug: GC Fuji IX, GC, Japan®
Drug: Activa TM Bioactive Restorative ®

Study type

Interventional

Funder types

Other

Identifiers

NCT05882760
LUMHS/REC/-29

Details and patient eligibility

About

There is a lack of long-term clinical studies comparing different restorative materials; most of the available studies have only looked at class I cavities or examined post-operative sensitivity in non-caries cervical lesions. The purpose of this study is to measure postoperative sensitivity in clinical settings at 3-month intervals for class 1 and 2 direct posterior restoration

Enrollment

160 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Either gender Minimum age 18 years, maximum age 40 years. Class I & II Cavity on maxillary and mandibular 1st and 2nd molars. Vital maxillary and mandibular molar teeth that had occlusal contact with antagonist teeth.

Exclusion criteria

Irreversible Pulpitis diagnosed clinically and radiographically. Class I & Class II cavity of premolars and third molars Patients taking analgesic prior to treatment. History of allergic reaction to any dental material used in the study. History of parafunctional habits (bruxism and/or clenching) Malocclusion

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Parallel Assignment

Masking

Double Blind

160 participants in 4 patient groups

Tetric N Bond Universal®
Experimental group
Description:
Cavities in this group will be restored with Conventional Hybrid Composite Restoration bonded with Etch \& Rinse Technique using Tetric N Bond Universal®.
Treatment:
Drug: Tetric N Bond Universal®
Self Etch Tetric N Bond Universal®
Active Comparator group
Description:
Cavities in this group will be restored with Conventional Hybrid Composite Restoration bonded with Self Etch Technique using Tetric N Bond Universal®.
Treatment:
Drug: Self Etch Tetric N Bond Universal®
GC Fuji IX, GC, Japan®
Active Comparator group
Description:
Cavities in this group will be restored with GC Fuji IX, GC, Japan®
Treatment:
Drug: GC Fuji IX, GC, Japan®
Activa TM Bioactive Restorative ®
Active Comparator group
Description:
Cavities in this group will be restored with Activa TM Bioactive Restorative ®
Treatment:
Drug: Activa TM Bioactive Restorative ®

Trial contacts and locations

1

Loading...

Central trial contact

Sarang Suresh, BDS; Priya Rani, BDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems